|
Quotes & Info
|
| PRI > SEC Filings for PRI > Form 10-K on 27-Feb-2013 | All Recent SEC Filings |
27-Feb-2013
Annual Report
Management's Discussion and Analysis of Financial Condition and Results of
Operations ("MD&A") is intended to inform the reader about matters affecting the
financial condition and results of operations of Primerica, Inc. (the "Parent
Company") and its subsidiaries (collectively, "we", "us" or the "Company") for
the three-year period ended December 31, 2012. As a result, the following
discussion should be read in conjunction with the consolidated and combined
financial statements and accompanying notes that are included herein. This
discussion contains forward-looking statements that constitute our plans,
estimates and beliefs. These forward-looking statements involve numerous risks
and uncertainties, including, but not limited to, those discussed in "Risk
Factors" Actual results may differ materially from those contained in any
forward-looking statements.
This MD&A is divided into the following sections:
• Business Trends and Conditions
• Factors Affecting Our Results
• Critical Accounting Estimates
• The April 2010 Transactions
• Results of Operations
• Financial Condition
• Liquidity and Capital Resources
Business Trends and Conditions
The relative strength and stability of financial markets and economies in the
United States and Canada affect our growth and profitability. Our business is,
and we expect will continue to be, influenced by a number of industry-wide and
product-specific trends and conditions.
Economic conditions, including high unemployment levels and low levels of
consumer confidence, influence investment and spending decisions by middle
income consumers, our primary clients. These conditions and factors also impact
prospective recruits' perceptions of the business opportunity that becoming a
Primerica sales representative offers, which can drive or dampen recruiting.
Consumer spending and borrowing levels remain under pressure, as consumers take
a more conservative financial posture, including reevaluating their savings and
debt management goals. As overall market and economic conditions have improved
and stabilized from the lows experienced during the recent economic downturn,
sales and the value of consumer investment products across a wide spectrum of
asset classes have improved.
Recruiting and Sales Representatives. Recruiting declined in 2012 to 191,752 new
recruits from 244,756 new recruits in 2011, due primarily to the strong prior
year recruiting surge that followed the announcement of short-term recruiting
incentives at our June 2011 biennial sales force convention.
Our ability to increase the size of our sales force is largely based on the
success of our recruiting efforts and our ability to train and motivate recruits
to get licensed. We believe that recruiting levels are an important advance
indicator of sales force trends, and growth in recruiting is usually indicative
of future growth in the overall size of the sales force. However, because new
recruits do not always obtain licenses, recruiting results do not always result
in commensurate increases in the size of our licensed sales force.
The size of our life-licensed sales force increased to 92,373 sales
representatives as of December 31, 2012 from 91,176 sales representatives at
December 31, 2011 primarily due to an increase in the licensing pull-through
rate. The improvement in the license pull-through rate was driven by our efforts
to balance the emphasis on recruiting and licensing in both our messaging and
incentive programs, as well as the introduction of streamlined life-licensing
processes for new recruits.
Term Life Insurance Product Sales and Face Amount In Force. We issued 222,558
new life insurance policies in 2012 compared with 237,535 new policies in 2011.
Sales of our term life insurance products typically correlate with the size of
our sales force and 2012 term life insurance product sales were lower than in
2011 largely as a result of the post-convention recruiting surge in the prior
year.
Our average issued face amount was approximately $243,000 in 2012 compared with
approximately $248,400 in 2011. The decrease is mostly attributable to a higher
mix of policies issued through TermNow, our rapid-issue term life insurance
product with policy face amounts of $250,000 and below. Total face amount in
force increased to approximately $670.4
billion as of December 31, 2012 compared with approximately $665.0 billion at
December 31, 2011 as new policies issued outpaced terminations.
Investment and Savings Product Sales and Asset Values. Investment and savings
products sales were higher in 2012, totaling approximately $4.7 billion,
compared with approximately $4.3 billion in 2011. The increase in sales was
largely attributable to new product introductions and increased demand for our
existing products.
The assets in our clients' accounts are invested in diversified funds comprised
mainly of U.S. and Canadian equity and fixed-income securities. The average
value of assets in client accounts increased to approximately $35.9 billion in
2012 from approximately $34.9 billion in 2011, while the period-end asset value
increased to approximately $37.4 billion at December 31, 2012 compared with
approximately $33.7 billion a year ago. The 2012 increases both in period-end
asset values and average client asset values were attributable to improved
market conditions and higher product sales.
Invested Asset Portfolio Size and Yields. Our portfolio continues to reflect
strong market value gains as interest rates and spreads continue to remain low.
As of December 31, 2012, our invested assets, excluding policy loans and cash,
had a cost or amortized cost basis of over $1.7 billion and a net unrealized
gain of $182.6 million compared with approximately $1.8 billion at cost or
amortized cost and net unrealized gain of $153.2 million at December 31, 2011.
If interest rates remain at or near historically low levels, we anticipate the
average yield of our portfolio, and therefore the investment income derived from
our portfolio, to decrease as maturing fixed income investments will be replaced
with purchases of lower yielding investments.
Legal Fees and Litigation-Related Expenses. Certain legal disputes have arisen
that have required us to incur significant legal costs, such as attorney's fees
and other litigation-related expenses. Unless the matters are resolved, we will
continue to incur significant legal fees and litigation-related expenses in
future periods. At this time, we are unable to reasonably estimate a range of
possible losses related to these legal disputes. For additional information, see
Note 15 (Commitments and Contingent Liabilities) to our consolidated and
combined financial statements.
Factors Affecting Our Results
Term Life Insurance Segment. Our Term Life Insurance segment results are
primarily driven by sales, accuracy of our pricing assumptions, terms and use of
reinsurance, investment income and expenses.
Sales and policies in force. Sales of new term policies and the size and
characteristics of our in-force book of policies are vital to our results over
the long term. Premium revenue is recognized as it is earned over the term of
the policy and eligible acquisition expenses are deferred and amortized ratably
with the level premiums of the underlying policies. However, because we incur
significant cash outflows at or about the time policies are issued, including
the payment of sales commissions and underwriting costs, changes in life
insurance sales volume will have a more immediate effect on our cash flows.
Historically, we have found that while sales volume of term life insurance
products between fiscal periods may vary based on a variety of factors, the
productivity of our individual sales representatives remains within a relatively
narrow range and, consequently, our sales volume over the longer term generally
correlates to the size of our sales force.
The average number of life-licensed sales representatives and the number of term
life insurance policies issued, as well as the average monthly rate of new
policies issued per life-licensed sales representative, were as follows:
Year ended December 31,
2012 2011 2010
Average number of life-licensed sales
representatives 90,981 91,855 96,840
Number of new policies issued 222,558 237,535 223,514
Average monthly rate of new policies issued per
life-licensed sales representative 0.20x 0.22x (1) 0.19x
____________________
|
During 2012, the average monthly rate of new policies issued per life-licensed
sales representative declined in comparison to the prior year primarily due to
the post-convention recruiting surge that generated significant sales referrals
and opportunities in 2011. The increased productivity of our individual sales
representatives in 2011 compared to 2010 was driven primarily by the
post-convention recruiting surge and sales of our TermNow product, which was
introduced during the year. As a result of these two factors, productivity for
2011 was at the high end of our historical range.
Pricing assumptions. Our pricing methodology is intended to provide us with
appropriate profit margins for the risks we assume. We determine pricing
classifications based on the coverage sought, such as the size and term of the
policy, and
certain policyholder attributes, such as age and health. In addition, we utilize
unisex rates for our term life insurance policies. The pricing assumptions that
underlie our rates are based upon our best estimates of mortality, persistency
and investment yields at the time of issuance, sales force commission rates,
issue and underwriting expenses, operating expenses and the characteristics of
the insureds, including sex, age, underwriting class, product and amount of
coverage. Our results will be affected to the extent there is a variance between
our pricing assumptions and actual experience.
• Persistency. Persistency is a measure of how long our insurance policies
stay in force. As a general matter, persistency that is lower than our
pricing assumptions adversely affects our results over the long term
because we lose the recurring revenue stream associated with the policies
that lapse. Determining the near-term effects of changes in persistency is
more complicated. When persistency is lower than our pricing assumptions,
we must accelerate the amortization of deferred policy acquisition costs
("DAC"). The resultant increase in amortization expense is offset by a
corresponding release of reserves associated with lapsed policies, which
causes a reduction in benefits and claims expense. The reserves associated
with any given policy will change over the term of such policy. As a
general matter, reserves are lowest at the inception of a policy term and
rise steadily to a peak before declining to zero at the expiration of the
policy term. Accordingly, depending on when the lapse occurs in relation
to the overall policy term, the reduction in benefits and claims expense
may be greater or less than the increase in amortization expense and,
consequently, the effects on earnings for a given period could be positive
or negative. Persistency levels will impact results to the extent actual
experience deviates from the persistency assumptions used to price our
products.
• Mortality. Our profitability is affected to the extent actual mortality rates differ from those used in our pricing assumptions. We mitigate a significant portion of our mortality exposure through reinsurance.
• Investment Yields. We use investment yield rates based on yields available at the time a policy is issued. For policies issued in 2010 and after, we have been using an increasing interest rate assumption to reflect the historically low interest rate environment. Both DAC and the reserve liability increase with the assumed investment yield rate. Since DAC is higher than the reserve liability in the early years of a policy, a lower assumed investment yield generally will result in lower profits. In the later years, when the reserve liability is higher than DAC, a lower assumed investment yield generally will result in higher profits. These assumed investment yields, which like other pricing assumptions are locked in at issue, impact the timing but not the aggregate amount of DAC and reserve changes. Actual investment yields will impact net investment income allocated to the Term Life Insurance segment, but will not impact DAC or the reserve liability.
Reinsurance. We use reinsurance extensively, which has a significant effect on
our results of operations. Since the mid-1990s, we have reinsured between 60%
and 90% of the mortality risk on our U.S. term life insurance policies on a
quota share yearly renewable term ("YRT") basis. In Canada, we previously
utilized reinsurance arrangements similar to the U.S. in certain years and
reinsured only face amounts above $500,000 in other years. However, in the first
quarter of 2012, we entered into a YRT reinsurance arrangement in Canada similar
to our U.S. program that reinsures 80% of the face amount for every policy sold.
YRT reinsurance permits us to set future mortality at contractual rates by
policy class. To the extent actual mortality experience is more or less
favorable than the contractual rate, the reinsurer will earn incremental profits
or bear the incremental cost, as applicable. In contrast to coinsurance, which
is intended to eliminate all risks (other than counterparty risk of the
reinsurer) and rewards associated with a specified percentage of the block of
policies subject to the reinsurance arrangement, the YRT reinsurance
arrangements we enter into are intended only to reduce volatility associated
with variances between estimated and actual mortality rates.
The effect of our reinsurance arrangements on ceded premiums and benefits and
expenses on our statement of income follows:
• Ceded premiums. Ceded premiums are the premiums we pay to reinsurers.
These amounts are deducted from the direct premiums we earn to calculate
our net premium revenues. Similar to direct premium revenues, ceded
coinsurance premiums remain level over the initial term of the insurance
policy. Ceded YRT premiums increase over the period that the policy has
been in force. Accordingly, ceded YRT premiums generally constitute an
increasing percentage of direct premiums over the policy term.
• Benefits and claims. Benefits and claims include incurred claim amounts and changes in future policy benefit reserves. Reinsurance reduces incurred claims in direct proportion to the percentage ceded. Coinsurance also reduces the change in future policy benefit reserves in direct proportion to the percentage ceded while YRT reinsurance does not significantly impact benefit reserves.
• Amortization of DAC. Amortization of DAC is reduced on a pro-rata basis for the coinsured business, including the business reinsured with Citigroup Inc. ("Citigroup"). There is no impact on amortization of DAC associated with our YRT contracts.
• Insurance expenses. Insurance expenses are reduced by the allowances received from coinsurance, including the business reinsured with Citigroup. There is no impact on insurance expenses associated with our YRT contracts.
We may alter our reinsurance practices at any time due to the unavailability of
YRT reinsurance at attractive rates or the availability of alternatives to
reduce our risk exposure. We presently intend to continue ceding approximately
90% of our U.S. mortality risk on new business and approximately 80% of our
Canadian mortality risk on new business.
Net investment income. Term Life Insurance segment net investment income is
composed of two elements: allocated net investment income and the market return
associated with the deposit asset underlying the 10% reinsurance agreement we
executed in connection with our corporate reorganization. Invested assets are
allocated to the Term Life segment based on the book value of the invested
assets necessary to meet statutory reserve requirements and our targeted capital
objectives. Net investment income is also impacted by the performance of our
invested asset portfolio and the market return on the deposit asset which can be
affected by interest rates, credit spreads and the mix of invested assets.
Expenses. Results are also affected by variances in client acquisition,
maintenance and administration expense levels.
Investment and Savings Products Segment. Our Investment and Savings Products
segment results are primarily driven by sales, the value of assets in client
accounts for which we earn ongoing management, service and distribution fees and
the number of fee generating accounts we administer.
Sales. We earn commissions and fees, such as dealer re-allowances, and marketing
and support fees, based on sales of mutual fund and managed account products and
annuities. Sales of investment and savings products are influenced by the
overall demand for investment products in the United States and Canada, as well
as by the size and productivity of our sales force. We generally experience
seasonality in our Investment and Savings Products segment results due to our
high concentration of sales of retirement account products. These accounts are
typically funded in February through April, coincident with our clients' tax
return preparation season. While we believe the size of our sales force is a
factor in driving sales volume in this segment, there are a number of other
variables, such as economic and market conditions, which may have a
significantly greater effect on sales volume in any given fiscal period.
Asset values in client accounts. We earn marketing and distribution fees (trail
commissions or, with respect to U.S. mutual funds, 12b-1 fees) on mutual fund
and annuity assets in the United States and Canada. In the United States, we
also earn investment advisory fees on assets in the managed accounts program. In
Canada, we earn management fees on certain mutual fund assets and on the
segregated funds for which we serve as investment manager. Asset values are
influenced by new product sales, ongoing contributions to existing accounts,
redemptions and the change in market values in existing accounts. While we offer
a wide variety of asset classes and investment styles, our clients' accounts are
primarily invested in equity funds.
Accounts. We earn recordkeeping fees for administrative functions we perform on
behalf of several of our retail and managed mutual fund providers and custodial
fees for services as a non-bank custodian for certain of our clients' retirement
plan accounts.
Sales Mix. While our investment and savings products all have similar long-term
earnings characteristics, our results in a given fiscal period will be affected
by changes in the overall mix of products within these broad categories.
Examples of changes in the sales mix that influence our results include the
following:
• sales of a higher proportion of mutual fund products of the several mutual
fund families for which we act as recordkeeper will generally increase our
earnings because we are entitled to recordkeeping fees on these accounts;
• sales of annuity products in the United States will generate higher revenues in the period such sales occur than sales of other investment products that either generate lower upfront revenues or, in the case of managed accounts and segregated funds, no upfront revenues;
• sales and administration of a higher proportion of mutual funds that enable us to earn marketing and support fees will increase our revenues and profitability;
• sales of a higher proportion of retirement products of several mutual fund families will tend to result in higher revenue generation due to our ability to earn custodial fees on these accounts; and
• sales of a higher proportion of managed accounts and segregated funds products will generally extend the time over which revenues can be earned because we are entitled to higher revenues based on assets under management for these accounts in lieu of upfront revenues.
Corporate and Other Distributed Products Segment. We earn revenues and pay
commissions and referral fees for various other insurance products, prepaid
legal services and other financial products, all of which are originated by
third parties. NBLIC also underwrites a mail-order student life policy and a
short-term disability benefit policy, neither of which is distributed by our
sales force, and has in-force policies from several discontinued lines of
insurance.
The Corporate and Other Distributed Products segment is affected by corporate
income and expenses not allocated to our other segments, net investment income
(other than net investment income allocated to our Term Life Insurance
segment), claims experience for policies underwritten by NBLIC, general and
administrative expenses (other than expenses that are allocated to our Term Life
Insurance or Investment and Savings Products segments), equity awards granted to
management and our sales force leaders at the time of our initial public
offering, interest expense on notes payable, and realized gains and losses on
our invested asset portfolio.
Capital Structure. Our financial results have also been affected by changes in
our capital structure that have occurred since our corporate reorganization in
2010, including the issuance of the $375.0 million in principal amount of senior
unsecured notes issued in 2012 (the "Senior Notes") and repayment of the note
payable to Citigroup, share repurchases, and other financing arrangements.
See Note 9 (Notes Payable), Note 11 (Stockholders' Equity) and Note 15
(Commitments and Contingent Liabilities) to our consolidated and combined
financial statements for more information on changes in our capital structure.
Critical Accounting Estimates
We prepare our financial statements in accordance with accounting principles
generally accepted in the United States of America ("U.S. GAAP"). These
principles are established primarily by the Financial Accounting Standards Board
("FASB"). The preparation of financial statements in conformity with U.S. GAAP
requires us to make estimates and assumptions based on currently available
information when recording transactions resulting from business operations. Our
significant accounting policies are described in Note 1 (Description of
Business, Basis of Presentation, and Summary of Significant Accounting Policies)
to our consolidated and combined financial statements. The most significant
items on the balance sheet are based on fair value determinations, accounting
estimates and actuarial determinations, which are susceptible to changes in
future periods and could affect our results of operations and financial
position.
The estimates that we deem to be most critical to an understanding of our
results of operations and financial position are those related to the valuation
of investments, DAC, future policy benefit reserves and corresponding amounts
due from reinsurers, litigation, and income taxes. The preparation and
evaluation of these critical accounting estimates involve the use of various
assumptions developed from management's analyses and judgments. Subsequent
experience or use of other assumptions could produce significantly different
results.
Invested Assets
We hold primarily fixed-maturity securities, including bonds and redeemable
preferred stocks, and equity securities, including common and non-redeemable
preferred stock. We have classified these invested assets as available-for-sale,
except for the securities of our U.S. broker-dealer subsidiary, which we have
classified as trading securities. All of these securities are carried at fair
value.
Fair value. Fair value is the price that would be received upon the sale of an
asset in an orderly transaction between market participants at the measurement
date. Fair value measurements are based upon observable and unobservable inputs.
Observable inputs reflect market data obtained from independent sources, while
unobservable inputs reflect our view of market assumptions in the absence of
observable market information. We classify and disclose all invested assets
carried at fair value in one of the three categories prescribed by Accounting
Standards Codification ("ASC") Topic 820, Fair Value Measurement.
As of each reporting period, we classify all invested assets in their entirety
based on the lowest level of input that is significant to the fair value
measurement. Significant levels of estimation and judgment are required to
determine the fair value of certain of our investments. The factors influencing
these estimations and judgments are subject to change in subsequent reporting
periods.
For additional information, see Note 1 (Description of Business, Basis of
Presentation, and Summary of Significant Accounting Policies), Note 3
(Investments) and Note 4 (Fair Value of Financial Instruments) to our
consolidated and combined financial statements.
Other-than-temporary impairments. We recognize unrealized gains and losses on
our available-for-sale portfolio as a separate component of accumulated other
comprehensive income. The determination of whether a decline in fair value below
amortized cost is other-than-temporary is subjective. Furthermore, this
determination can involve a variety of assumptions and estimates, particularly
for invested assets that are not actively traded in established markets. We
evaluate a number of factors when determining the impairment status of
individual securities. These factors include the economic condition of various
industry segments and geographic locations and other areas of identified risk.
For available-for-sale securities in an unrealized loss position that we intend
to sell or would more-likely-than-not be required to sell before the expected
recovery of the amortized cost basis, we recognize an impairment charge for the
difference between amortized cost and fair value as a realized investment loss
in our statements of income. For available-
for-sale securities in an unrealized loss position for which we have no intent
to sell and believe that it is more-likely-than-not that we will not be required
to sell before the expected recovery of the amortized cost basis, only the
credit loss component of the difference between cost and fair value is
recognized in earnings, while the remainder is recognized in accumulated other
comprehensive income. The credit loss component recognized in earnings is
identified as the amount of principal cash flows not expected to be received
over the remaining term of the security.
For certain securitized financial assets with contractual cash flows, including
asset-backed securities, we periodically update our best estimate of cash flows
over the life of the security. Securities that are in an unrealized loss
position are reviewed at least quarterly for other-than-temporary impairment. If
the fair value of a securitized financial asset is less than its cost or
amortized cost and there has been a decrease in the present value of the
estimated cash flows since the last revised estimate, considering both timing
and amount, an other-than-temporary impairment charge is recognized. Estimating
. . .
|
|